Full Name
David Radley
Hospital/Organisation/Company
Pfizer
Speaker Bio
David Radley is Executive Director, Vaccines Clinical Research at Pfizer in Pearl River, NY, USA. He holds an MSc.
in Biometry from Reading University, UK. He has worked in pharmaceutical development for 35 years, first in the UK and then since 1997 in the United States, when Rhone-Poulenc Rorer moved him to their headquarters in Pennsylvania. Since 2000, he has focused on vaccine research including HPV, meningococcal, staph aureus, RSV and GBS vaccines; first at Merck and (since 2014) at Pfizer.
He has regularly presented his research at scientific meetings on subjects as diverse as multicenter trials, combination of endpoints, noninferiority studies, data monitoring committees and long-term vaccine effectiveness monitoring.
in Biometry from Reading University, UK. He has worked in pharmaceutical development for 35 years, first in the UK and then since 1997 in the United States, when Rhone-Poulenc Rorer moved him to their headquarters in Pennsylvania. Since 2000, he has focused on vaccine research including HPV, meningococcal, staph aureus, RSV and GBS vaccines; first at Merck and (since 2014) at Pfizer.
He has regularly presented his research at scientific meetings on subjects as diverse as multicenter trials, combination of endpoints, noninferiority studies, data monitoring committees and long-term vaccine effectiveness monitoring.
